{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:11:18Z","timestamp":1776474678863,"version":"3.51.2"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004493","name":"International Atomic Energy Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.xphs.2021.03.021","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T23:59:32Z","timestamp":1617321572000},"page":"2955-2965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Amelioration of Tumor Targeting and\u00a0In Vivo\u00a0Biodistribution of\u00a099mTc-Methotrexate-Gold Nanoparticles (99mTc-Mex-AuNPs)"],"prefix":"10.1016","volume":"110","author":[{"given":"DM","family":"El-Safoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-0429","authenticated-orcid":false,"given":"Ahmed Badr","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"El-Setouhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OM","family":"Khowessah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Motaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.03.021_bib0001","first-page":"2525","article-title":"Cancer facts and figures","volume":"21","year":"2017","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.xphs.2021.03.021_bib0002","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.bios.2008.10.018","article-title":"Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres","volume":"24","author":"Lee","year":"2009","journal-title":"Biosens Bioelectron"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0003","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10549-010-1257-5","article-title":"Ran-domized phase III trial of adjuvant epirubicin followed by cyclophosphamide,methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1\u20133 node-positive rapidly proliferating breast cancer","volume":"125","author":"Amadori","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0004","first-page":"2587","article-title":"New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells","volume":"25","author":"Neradil","year":"2012","journal-title":"Klin Onkol"},{"key":"10.1016\/j.xphs.2021.03.021_bib0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ccr.2018.01.007","article-title":"Emerging nanomaterials with advanced drug delivery functions; focused on methotrexate delivery","volume":"359","author":"Choi","year":"2018","journal-title":"Coord Chem Rev"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2710.2006.00726.x","article-title":"Is \u2018chemofog\u2019\/\u2018chemo-brain\u2019 caused by cancer chemotherapy?","volume":"31","author":"Raffa","year":"2006","journal-title":"J. Clin Pharm Ther"},{"key":"10.1016\/j.xphs.2021.03.021_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bej.2013.04.017","article-title":"Synthesis of methotrexate-conjugated gold nanoparticles with enhanced cancer therapeutic effect","volume":"78","author":"Tran","year":"2013","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.xphs.2021.03.021_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.msec.2017.05.049","article-title":"Methotrexate-loaded nitrogen-doped graphene quantum dots nanocarriers as an efficient anticancer drug delivery system","volume":"79","author":"Khodadadei","year":"2017","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.xphs.2021.03.021_bib0009","first-page":"4107","article-title":"Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy","volume":"29","author":"Ting","year":"2009","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.03.021_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S1679-45082016RB3475","article-title":"Advances in the use of nanocarriers for cancer diagnosis and treatment","volume":"14","author":"D\u00e9bora","year":"2016","journal-title":"Einstein"},{"key":"10.1016\/j.xphs.2021.03.021_bib0011","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.crci.2017.11.010","article-title":"Novel PEI-AuNPs-Mn III PPIX nanocomposite with enhanced peroxidase-like catalytic activity in aqueous media","volume":"21","author":"Xie","year":"2018","journal-title":"C R Chim"},{"key":"10.1016\/j.xphs.2021.03.021_bib0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.talanta.2018.05.084","article-title":"A highly sensitive colorimetric probe for Cd2+, Hg2+ and ascorbic acid determination based on trithiocyanuric acid-AuNPs","volume":"188","author":"Wang","year":"2018","journal-title":"Talanta"},{"issue":"24","key":"10.1016\/j.xphs.2021.03.021_bib0014","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.3390\/molecules25246049","article-title":"Methotrexate gold nanocarriers: loading and release study: its activity in colon and lung cancer cells","volume":"25","author":"\u00c1lvarez-Gonz\u00e1lez","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.xphs.2021.03.021_bib0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/mp060132k","article-title":"Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model","volume":"4","author":"Chen","year":"2007","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.03.021_bib0016","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s11671-015-0864-9","article-title":"Iodine-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent","volume":"10","author":"Su","year":"2015","journal-title":"Nanoscale Res Lett"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15171\/bi.2016.23","article-title":"Radiolabeled theranostics: magnetic and gold nanoparticles","volume":"6","author":"Same","year":"2016","journal-title":"Bioimpacts"},{"key":"10.1016\/j.xphs.2021.03.021_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejps.2018.06.029","article-title":"I-131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery","volume":"122","author":"Sakr","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2021.03.021_bib0019","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1021\/acs.chemmater.6b01796","article-title":"Missing piece of the mechanism of the turkevich method: the critical role of citrate protonation","volume":"28","author":"Kettemann","year":"2016","journal-title":"Chem Mater"},{"key":"10.1016\/j.xphs.2021.03.021_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/df9511100055","article-title":"A Study of the nucleation and growth processes in the synthesis of colloidal gold","volume":"11","author":"Turkevich","year":"1951","journal-title":"Discuss Faraday Soc"},{"issue":"11","key":"10.1016\/j.xphs.2021.03.021_bib0021","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1039\/b517615h","article-title":"Gold nanostructures: engineering their plasmonic properties for biomedical applications","volume":"35","author":"Hu","year":"2006","journal-title":"Chem Soc Rev"},{"issue":"18","key":"10.1016\/j.xphs.2021.03.021_bib0022","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1039\/C9RA08657A","article-title":"Synthesis of controlled-size silver nanoparticles for the administration of methotrexate drug and its activity in colon and lung cancer cells","volume":"10","author":"Rozalen","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2021.03.021_bib0023","first-page":"33","article-title":"Characterization of pharmaceutical nanocarriers: in vitro and in vivo studies","volume":"2","author":"Vinod","year":"2019"},{"issue":"8","key":"10.1016\/j.xphs.2021.03.021_bib0024","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2012.08.009","article-title":"Nanocarriers for topical administration of resveratrol: a comparative study","volume":"440","author":"Scognamiglio","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.03.021_bib0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/10717544.2017.1410262","article-title":"Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies\u201d","volume":"25","author":"Fahmy","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.03.021_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119514","article-title":"99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent","volume":"586","author":"El-Ghareb","year":"2020","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0028","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982104.2013.801489","article-title":"Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization","volume":"23","author":"Shamma","year":"2013","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2021.03.021_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111715","article-title":"Biomimetic gold nanoparticles for its cytotoxicity and biocompatibility evidenced by fluorescence-based assays in cancer (MDA-MB-231) and non-cancerous (HEK-293) cells","author":"Jeyarani","year":"2020","journal-title":"J Photochem Photobiol B Biol"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10856-019-6221-2","article-title":"Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. evaluation of the safety of use and anti-cancer potential","volume":"30","author":"Steckiewicz","year":"2019","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.xphs.2021.03.021_bib0031","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/IJN.S165289","article-title":"Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production","volume":"13","author":"Mart\u00ednez-Torres","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2021.03.021_bib0032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1208\/s12249-019-1380-5","article-title":"Enhanced permeation of methotrexate via loading into ultra-permeable niosomal vesicles: fabrication, statistical optimization, Ex Vivo studies, and In Vivo skin deposition and tolerability","volume":"20","author":"Abdulaziz","year":"2019","journal-title":"AAPS Pharm Sci Tech"},{"issue":"25","key":"10.1016\/j.xphs.2021.03.021_bib0033","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1039\/C5NR01382H","article-title":"Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo","volume":"7","author":"Peng","year":"2015","journal-title":"Nanoscale"},{"issue":"8","key":"10.1016\/j.xphs.2021.03.021_bib0034","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jlcr.3060","article-title":"Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging","volume":"56","author":"Sakr","year":"2013","journal-title":"J Labelled Comp Radiopharm"},{"issue":"10","key":"10.1016\/j.xphs.2021.03.021_bib0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jlcr.3223","article-title":"Radioiodinated acebutolol as a new highly selective radiotracer for myocardial perfusion imaging","volume":"57","author":"Swidan","year":"2014","journal-title":"J Labelled Comp Radiopharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0036","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10967-018-6013-z","article-title":"Radioiodinated doxorubicin as a new tumor imaging model: preparation, biological evaluation, docking and molecular dynamics","volume":"317","author":"Ibrahim","year":"2018","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0037","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s10967-017-5551-0","article-title":"A novel radiolabeled indole derivative as solid tumor imaging agent: in silico and preclinical pharmacological study","volume":"314","author":"Shamsel-Din","year":"2017","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.xphs.2021.03.021_bib0038","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejps.2016.05.002","article-title":"Intranasal haloperidol-loaded miniemulsions for brain targeting: evaluation of locomotor suppression and in-vivo biodistribution","volume":"92","author":"El-Setouhy","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2021.03.021_bib0039","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/js9900295","article-title":"Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats","volume":"88","author":"Chow","year":"1999","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2021.03.021_bib0040","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative biodistribution and pharmacokinetic analysis of cyclosporine-a in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation","volume":"12","author":"Yadav","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2021.03.021_bib0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2021.03.021_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies. a review","volume":"15","author":"Hossen","year":"2018","journal-title":"J Adv Res"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0043","doi-asserted-by":"crossref","first-page":"72","DOI":"10.14202\/vetworld.2014.72-77","article-title":"Gold nanoparticle: synthesis and characterization","volume":"7","author":"Verma","year":"2014","journal-title":"Vet World"},{"key":"10.1016\/j.xphs.2021.03.021_bib0044","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14356\/kona.2020011","article-title":"Synthesis of precision gold nanoparticles using turkevich method","volume":"37","author":"Dong","year":"2020","journal-title":"Kona Powder Sci Technol Jpn"},{"key":"10.1016\/j.xphs.2021.03.021_bib0045","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.2147\/IJN.S31219","article-title":"Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit candida albicans biofilm","volume":"7","author":"Khan","year":"2012","journal-title":"Int J Nanomed"},{"issue":"7","key":"10.1016\/j.xphs.2021.03.021_bib0046","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-2952(03)00468-4","article-title":"Tumor acidity, ion trapping and chemotherapeutics: II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents","volume":"66","author":"Raghunand","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"46","key":"10.1016\/j.xphs.2021.03.021_bib0047","doi-asserted-by":"crossref","first-page":"19611","DOI":"10.1039\/C5NR05826K","article-title":"Adsorption of doxorubicin on citrate-capped gold nanoparticles: insights into engineering potent chemotherapeutic delivery systems","volume":"7","author":"Curry","year":"2015","journal-title":"Nanoscale"},{"issue":"13","key":"10.1016\/j.xphs.2021.03.021_bib0048","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/imt-2018-0029","article-title":"Gold nanoparticles-mediated photothermal therapy and immunotherapy","volume":"10","author":"Liu","year":"2018","journal-title":"Immunotherapy"},{"issue":"42","key":"10.1016\/j.xphs.2021.03.021_bib0049","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1039\/b914071a","article-title":"Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers","volume":"19","author":"Aryal","year":"2009","journal-title":"J Mater Chem"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/1061186X.2017.1365876","article-title":"Doxorubicin-conjugated D-glucosamine-and folate-bi-functionalised InP\/ZnS quantum dots for cancer cells imaging and therapy","volume":"26","author":"Ranjbar-Navazi","year":"2018","journal-title":"J Drug Target"},{"issue":"118","key":"10.1016\/j.xphs.2021.03.021_bib0051","doi-asserted-by":"crossref","first-page":"97330","DOI":"10.1039\/C5RA12892G","article-title":"One pot synthesis of doxorubicin loaded gold nanoparticles for sustained drug release","volume":"5","author":"Chaudhary","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2021.03.021_bib0052","first-page":"495","article-title":"Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake","volume":"9","author":"Cho","year":"2014","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0053","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop J Pharm Res"},{"issue":"14","key":"10.1016\/j.xphs.2021.03.021_bib0054","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.biomaterials.2013.01.084","article-title":"Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery","volume":"34","author":"Cheng","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2021.03.021_bib0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcis.2017.08.050","article-title":"Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy","volume":"508","author":"Yang","year":"2017","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.xphs.2021.03.021_bib0056","series-title":"handbook of materials for nanomedicine","first-page":"190","article-title":"Polymeric micelles as versatile carriers for drugs and nucleic acids delivery","author":"Torchilin","year":"2010"},{"issue":"5","key":"10.1016\/j.xphs.2021.03.021_bib0057","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1535-7163.MCT-06-0024","article-title":"Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics","volume":"5","author":"Gerweck","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.xphs.2021.03.021_bib0058","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/jp026731y","article-title":"The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment","volume":"107","author":"Kelly","year":"2003","journal-title":"J Phys Chem B"},{"issue":"8","key":"10.1016\/j.xphs.2021.03.021_bib0059","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.xphs.2021.03.021_bib0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4155\/tde.12.21","article-title":"Size matters: gold nanoparticles in targeted cancer drug delivery","volume":"3","author":"Dreaden","year":"2012","journal-title":"Ther Deliv"},{"issue":"7","key":"10.1016\/j.xphs.2021.03.021_bib0061","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/ijms19071979","article-title":"Gold nanoparticles in diagnostics and therapeutics for human cancer","volume":"19","author":"Singh","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.03.021_bib0062","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/nnm.10.23","article-title":"Understanding and overcoming major barriers in cancer nanomedicine","volume":"5","author":"Nie","year":"2010","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.03.021_bib0063","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2010.06.049","article-title":"Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in ehrlich ascites tumor bearing mice","volume":"397","author":"Mondal","year":"2010","journal-title":"IntJ Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2021.03.021_bib0064","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2021.03.021_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmcokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.03.021_bib0066","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?.","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Theranostic"},{"issue":"2","key":"10.1016\/j.xphs.2021.03.021_bib0067","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12272-017-0995-x","article-title":"Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications","volume":"41","author":"Ruttala","year":"2018","journal-title":"Arch Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:06Z","timestamp":1758360726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0022354921001908"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.03.021","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of Tumor Targeting and\u00a0In Vivo\u00a0Biodistribution of\u00a099mTc-Methotrexate-Gold Nanoparticles (99mTc-Mex-AuNPs)","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}